IntelGenx Technologies Corp (IGXT)

[specular]

Well the other reality - that you conveniently forget to mention - is that they currently have the best product in a $200M a year market. That product has no competition from a performance perspective, yet they have captured less than 2% of the market.

Point being is that even Zerbe - as business illiterate as he is - will begin to build some momentum and start to capture a greater % of the max strength Bupropion market. The potential just from this one product is rather significant - again no competition for their product in a $200M a year market. They should easily be generating $5M a year on this product.

If Edgemont hasn't started to figure this out after 2+ years - time to cut the cord with them and find a new partner. That announcement alone would double the price of the stock.

Just listing past numbers on the company can be dangerous (and then assume nothing can / will change). They have a great product - unfortunately they have an equally poor business leader.